Zongertinib

Product Name: Zongertinib
CAS No.: 2728667-27-2
Chemical Name: Zongertinib
Synonyms: BI-1810631;Zongertinib;Zostertinib;BLU-451(LNG451);Toremifen citrate;Zostertinib BI-1810631;Zongertinib/BI 1810631;azol-5-yl)oxy]phenyl]amino]pyrimido[5,4-d]pyrimidin-2-yl]-4-piperidinyl]-;N-[1-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxy-anilino]pyrimido[5,4-d]pyrimidin-6-yl]-4-piperidyl]prop-2-enamide;N-(1-(8-((3-methyl-4-((1-methyl-1H-benzo[d]imidazol-5-yl)oxy)phenyl)amino)pyrimido[5,4-d]pyrimidin-2-yl)piperidin-4-yl)acrylamide
CBNumber: CB512094450
Molecular Formula: C29H29N9O2
Formula Weight: 535.6
MOL File: 2728667-27-2.mol

More

Less

Zongertinib Property

Density: 1.39±0.1 g/cm3(Predicted)
form: Solid
pka: 14.16±0.20(Predicted)
color: Light yellow to green yellow
InChIKey: YSGNGFPNTLERCR-UHFFFAOYSA-N
SMILES: C(NC1CCN(C2=NC=C3N=CN=C(NC4=CC=C(OC5=CC=C6N(C)C=NC6=C5)C(C)=C4)C3=N2)CC1)(=O)C=C

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

Zongertinib Chemical Properties,Usage,Production

Description

Zongertinib (also known as BI 1810631) is an investigational irreversible tyrosine kinase inhibitor (TKI) that selectively inhibits HER2 (ERBB2) while inhibiting epidermal growth factor receptor (EGFR), thereby limiting associated toxicity. This oral targeted therapy is being developed for the treatment of advanced non-small cell lung cancer (NSCLC) with HER2 (ERRB2) mutations.

Uses

Zongertinib (BI 1810631) is a potent and selective HER2 and EGFR tyrosine kinase inhibitor with IC50 values of 13 nM and 579 nM, respectively. Zongertinib has antitumor activity and can be used in the study of multiple solid tumors[1][2][3].

References

[1] WHO Drug Informat ion - World Health Organization (WHO).
[2] Wilding Birgit, et al. Synthesis of diazino-pyrimidines as anticancer agents: World Intellectual Property Organization, WO2021213800. 2021-10-28.
[3] Li S, et al. Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer. Cancers (Basel). 2023 May 24;15(11):2899. DOI:10.3390/cancers15112899

Zongertinib Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Zongertinib Suppliers

China 74 Global 74

CAREBIO PHARMA

Tel: 18501057619 18501057619;
Email: jackyfan@rebornpharma.com
Country: China
ProdList: 275
Advantage: 58

Jinan Chuanbei Biotechnology Co., Ltd

Tel: 18654547380; 15269175648
Fax: 0531-67802093
Email: qingyan7590@163.com
Country: China
ProdList: 17
Advantage: 58

Jinan shenlikang chemical technology co. LTD

Tel: 0531-86092839 13153040268
Fax: QQ：2425815073
Email: 2425815073@qq.com
Country: China
ProdList: 266
Advantage: 58

Anqing Benro pharmachem Technology Co.,Ltd.

Tel: 05565209906 15391842992
Email: 794263564@qq.com
Country: China
ProdList: 126
Advantage: 58

JiNan QiYuan Biotechnology Co., Ltd

Tel: 18766124282; 18766124282
Email: 18766124282@163.COM
Country: China
ProdList: 951
Advantage: 58

Jurong Coupling Biotechnology Co., Ltd.

Tel: 19231718652
Email: 278191416@qq.com
Country: China
ProdList: 480
Advantage: 58

Shanghai Hope Chem Co., Ltd.，

Tel: +21-18501659228 18501659228
Fax: sales@hope-chem.com
Email: info@hope-chem.com
Country: China
ProdList: 483
Advantage: 55

Shandong utilizing biological technology co., LTD

Tel: 15966937598
Fax: 3407640895 3071519937
Email: 3407650895@qq.com
Country: China
ProdList: 5063
Advantage: 58

WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.

Tel: 17702719238 18971495150;
Email: sales@sun-shinechem.com
Country: China
ProdList: 1112
Advantage: 64

Shanghai Boc Chemical Co.,Ltd

Tel: 021-34975603-808 18721111801
Fax: +86-21-34975602-805
Email: sales@bocpharma.com
Country: China
ProdList: 1003
Advantage: 64

More

Less

View Lastest Price from Zongertinib manufacturers

HangZhou RunYan Pharma Technology Co.,LTD.

Product: Zongertinib; BI-1810631 2728667-27-2
Price: US $0.00-0.00/mg
Min. Order: 10mg
Purity: 99% HPLC
Supply Ability: 10000
Release date: 2024-09-19

2728667-27-2, ZongertinibRelated Search:

2-Propenamide, N-[1-[8-[[3-methyl-4-[(1-methyl-1H-benzimidazol-5-yl)oxy]phenyl]amino]pyrimido[5,4-d]pyrimidin-2-yl]-4-piperidinyl]-

N-[1-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxy-anilino]pyrimido[5,4-d]pyrimidin-6-yl]-4-piperidyl]prop-2-enamide

Zongertinib

N-(1-(8-((3-methyl-4-((1-methyl-1H-benzo[d]imidazol-5-yl)oxy)phenyl)amino)pyrimido[5,4-d]pyrimidin-2-yl)piperidin-4-yl)acrylamide

BI-1810631

Zongertinib/BI 1810631

BLU-451(LNG451)

Toremifen citrate

azol-5-yl)oxy]phenyl]amino]pyrimido[5,4-d]pyrimidin-2-yl]-4-piperidinyl]-

Zostertinib

Zostertinib BI-1810631

N-{1-[8-({3-methyl-4-[(1-methyl-1H-1,3-benzodiazol-5-yl)oxy]phenyl}amino)-[1,3]diazino[5,4-d]pyrimidin-2-yl]piperidin-4-yl}prop-2-enamide

2728667-27-2

C29H29N9O2

API